US diagnostic imaging market faces tariff-driven supply chain and capital risks, reveals GlobalData

New tariffs drive uncertainty in diagnostic imaging procurement, with hospitals and manufacturers facing rising costs, delayed investments, and disrupted access to CT and MRI systems, says GlobalData